Close
ACHEMA MIDDLE EAST 2026
5th LNP Formulation & Process Development Summit

Drug Development

      Eloxx Pharmaceuticals Announces Initiation of Phase 2 Clinical Trial for ELX 02 in Cystinosis

      Clinical Trials
      Eloxx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel therapeutics to treat cystic fibrosis, cystinosis, inherited retinal disorders,...

      Vesselon Acquires FDA-Approved Lipid Microsphere Drug Imagent For Therapeutic Platform

      FDA Approvals
      Vesselon (www.vesselon.com) an oncology therapeutics company, announced the acquisition of an FDA-approved drug Imagent. Vesselon will use Imagent to create novel therapeutic complexes in...

      ADC Therapeutics and SOPHiA GENETICS Partner for Biomarker Discovery in Pivotal Phase II Clinical Trial

      Clinical Trials
      ADC Therapeutics, an oncology drug discovery and development company that specializes in the development of antibody drug conjugates (ADCs), and SOPHiA GENETICS, a leader...

      Nucala receives EU approval for self administration by patients with severe eosinophilic asthma

      FDA Approvals
      GlaxoSmithKline  announced that the European Commission has granted marketing authorisation for two new methods of administering Nucala (mepolizumab): a pre-filled pen and a pre-filled...

      Neuropore Therapies and BenevolentAI Enter Strategic Collaboration to Discover Novel Therapeutics Through the Application of Artificial Intelligence

      News
      Neuropore Therapies, Inc. announce that it entered into a collaboration with BenevolentAI to evaluate molecular targets implicated in progressive degenerative diseases which were identified...

      Dr. Reddys Laboratories announces the launch of Pregabalin Capsules in the U.S. Market

      Drug Development
      Dr. Reddy’s Laboratories Ltd, along with its subsidiaries together referred to as “Dr. Reddy’s” announced the launch of Pregabalin Capsulesa therapeutic equivalent generic version...

      Amicus Announces Positive Interim Clinical Data for AAV Gene Therapy in Children with CLN6 Batten Disease

      Clinical Trials
      Amicus Therapeutics announced positive interim results from its CLN6 Batten disease gene therapy program licensed from the Abigail Wexner Research Institute (AWRI) at Nationwide...

      Subscribe Our Newsletter

      White Papers

      The Future of Digital Health

      Whitepapers 0
      The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

      Five Best Practices to Deliver Exceptional Multichannel Experiences

      Whitepapers 0
      A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

      The Impact and Use of Social Media in Pharmacovigilance

      Whitepapers 0
      Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...

      About us

      Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and
      comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector. . . Read More

      Resources

      Advertise

      Subscribe

      Copyright © Value Media Group 2026. All rights reserved.